Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Jaguar Health, Inc. (JAGX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Jaguar Health, Inc. (JAGX), most recent 12 months reported: revenue $27.82M, net loss $36.4M, free cash flow -$23.73M. Latest balance sheet on file: liquid cash $3.79M, total debt $15.56M, net cash -$11.77M. From SEC filings. Others in Pharmaceutical Preparations: Cumberland Pharmaceuticals Inc. · Verrica Pharmaceuticals Inc. · ARCTURUS THERAPEUTICS HOLDINGS INC. · TONIX PHARMACEUTICALS HOLDING CORP. · Stoke Therapeutics, Inc. · ABEONA THERAPEUTICS INC. · Janux Therapeutics, Inc. · PRELUDE THERAPEUTICS INC

Stock screener

Watchlist